Leukemia, Acute Lymphoblastic: Clinical Trials

4 trials for Leukemia, Acute Lymphoblastic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting. 4 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Recruiting 2
Phase 23Recruiting 2, Completed 1

Follow Leukemia, Acute Lymphoblastic: new trials by email Literature Review of Leukemia, Acute Lymphoblastic trials Research Report on Leukemia, Acute Lymphoblastic

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
Autologous HuCD19 ( Anti-CD19)CAR T cells, Cyclophosphamide, Fludarabine - Leukemia, Lymphocytic, Chronic, B-Cell, B-Lymphocytic Leukemia, Chronic
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)1322024-09-032026-10-16
CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma
CART-19 - Leukemia, Acute Lymphoblastic, Lymphoma, Non-Hodgkin
Phase 1 / Phase 2RecruitingUniversity of Sao Paulo812024-03-212024-12-09
Safety of Expanded Haploidentical Natural Killer Cells for Leukemia
Expanded Haploidentical Natural Killer cells, IL-2 - Leukemia, Acute Myeloid, Leukemia, Acute Lymphoblastic
Phase 1CompletedBelarusian Research Center for Pediatric Oncology, Hematology and Immunology102019-01-022022-03-02
GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia
Allogeneic stem cell transplantation, Fludarabine monophosphate, Busulfan - Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia
Phase 1 / Phase 2CompletedSt. Petersburg State Pavlov Medical University272016-06-012020-11-23

Narrower conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma (4)  ·  Leukemia, Myeloid, Acute (2)  ·  Immune System Diseases (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)

Broader conditions

Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Immunoproliferative Disorders (4)  ·  Leukemia (4)  ·  Leukemia, Lymphoid (4)  ·  Lymphatic Diseases (4)  ·  Lymphoproliferative Disorders (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Immune System Diseases (3)  ·  Leukemia, Myeloid (2)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Leukemia, B-Cell (1)  ·  Pathologic Processes (1)

Interventions

Bendamustine Hydrochloride (1)  ·  Busulfan (1)  ·  CTL019 chimeric antigen receptor (1)  ·  Cyclophosphamide (1)  ·  Interleukin-2 (1)  ·  Rituximab (1)  ·  fludarabine (1)  ·  fludarabine phosphate (1)

Sponsors

Belarusian Research Center for Pediatric Oncology, Hematology and Immunology (1)  ·  National Cancer Institute (NCI) (1)  ·  St. Petersburg State Pavlov Medical University (1)  ·  University of Sao Paulo (1)

Countries

Belarus (1)  ·  Brazil (1)  ·  Russia (1)  ·  United States (1)

Top investigators

Boris V. Afanasyev, Professor (1)  ·  Diego V Cle, MD, PhD, MBA (1)  ·  James N Kochenderfer, M.D. (1)  ·  Olga Aleinikova (1)

Results publications

PMID 36527513